Yüklüyor......
Stigmasterol sensitizes endometrial cancer cells to chemotherapy by repressing Nrf2 signal pathway
Abstract Background Chemoresistance reduces the 5-year survival rate of endometrial cancer patient, which is the current major obstacle for cancer therapy. Increasing evidence state that Nrf2 contributes to chemoresistance in several kinds of cancer. However, its role in endometrial cancer cells rem...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2020-10-01
|
| Seri Bilgileri: | Cancer Cell International |
| Konular: | |
| Online Erişim: | http://link.springer.com/article/10.1186/s12935-020-01470-x |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|